Three medications that treat heartburn are being recalled because the medications may contain an impurity that could cause cancer, according to notices from the U.S. Food and Drug Administration (FDA).
The FDA said that Denton Pharma Inc had recalled several batches of unexpired ranitidine tablets due to the possible presence of N-Nitrosodimethylamine NDMA, NBC reported on Friday.
In an announcement last Wednesday, the FDA also said that the drug company Mylan has recalled three lots of another antacid, nizatidine, which were also found to contain trace amounts of NDMA.
Additionally, Mylan global announced earlier this week that its USA -based pharmaceutical business conducted a voluntary recall of three lots of 150 mg and 300 mg nizatidine capsules, which are known by the brand name Axid, and provide short-term treatment of ulcers and GERD, similarly over NDMA. NDMA is a known environmental contaminant that is found in water and foods, including meats, dairy products and vegetables. The FDA has been investigating NDMA since 2018. Ranitidine Capsules 150 mg and Ranitidine Capsules 300 mg were distributed nationwide.
Texans-KC set NFL playoff record with 52 points in 1st half
Houston also traded for running backs Carlos Hyde and Duke Johnson before the start of the season. He's going to get all of my 110% every time I step on that field.
Maple Leaf Foods CEO McCain blasts US for Iran's jet downing
She would not confirm the identities of the victims related to a Maple Leaf Foods employee, citing the family's need for privacy. Maple Leaf Foods plans to open a large poultry plant in London, slated to begin operations in 2021.
Rene Zellweger Loaned Her A Gown
Fortunately, Zellweger had an extra dress and Hayek managed to get to the show and still look incredible . Because what does that mean?" "It means you have to pretend you're okay to go and do the following".
Appco Pharma LLC has also recalled ranitidine products. Certain chemical reactions can accidentally bring NDMA into certain products.
Nizatidine is indicated for short-term treatment of active duodenal ulcers and active benign gastric ulcers, for maintenance therapy of duodenal ulcer patients, and for the treatment of endoscopically diagnosed esophagitis and associated heartburn due to gastroesophageal reflux disease.
The recalled medications include 60-count bottles of 150mg Nizatidine Capsules, USP expiring in May of 2020 with lot number 3086746; 30-count bottles of 300mg Nizatidine Capsules, USP expiring in January of 2020 with lot number 3082876; and 30-count bottles of 300mg Nizatidine Capsules, USP expiring in January of 2020 with lot number 3082877, according to Mylan.
USFDA classifies a Class II recall as one in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.